NCT07326358 AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective Study
| NCT ID | NCT07326358 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ruijin Hospital |
| Condition | Nasopharyngeal Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-12-12 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2025-12-12 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
An artificial intelligence-assisted system is trained and validated by collecting nasopharyngolaryngoscopy images from patients.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years; * Underwent standard electronic nasopharyngolaryngoscopy; * Patients who underwent biopsy sampling have a clear pathological diagnosis; * Signed a written informed consent form. Exclusion Criteria: * Image quality is substandard with severe motion artifacts; * Lesion images are unclear and incomplete.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07326358 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Nasopharyngeal Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07326358 currently recruiting?
Yes, NCT07326358 is actively recruiting participants. Contact the research team at aydyebin@126.com for enrollment information.
Where is the NCT07326358 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT07326358 clinical trial?
NCT07326358 is sponsored by Ruijin Hospital. The trial plans to enroll 500 participants.